Open AccessRandomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
Author(s) -
Constant V.M. Verschuur,
Sven R. Suwijn,
Judith A. Boel,
Bart Post,
Bas R. Bloem,
Johannes J. van Hilten,
Teus van Laar,
Gerrit Tissingh,
Alexander G. Munts,
Günther Deuschl,
Anthony E. Lang,
Marcel G. W. Dijkgraaf,
Rob J. de Haan,
Rob M.A. de Bie
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1809983
Subject(s) - levodopa , medicine , parkinson's disease , disease , randomized controlled trial , drug trial , clinical trial , physical therapy
Levodopa is the main treatment for symptoms of Parkinson's disease. Determining whether levodopa also has a disease-modifying effect could provide guidance as to when in the course of the disease the treatment with this drug should be initiated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom